MT-2766
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MT-2766, covering 2023-05-01 to 2023-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety Immunogenicity Study of MT-2766 in Japanese Adults(COVID-19) [Phase 1, Phase 2]